Ignite Creation Date:
2024-05-06 @ 1:29 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01822275
Status:
TERMINATED
Last Update Posted:
2022-12-29
First Post:
2013-03-22
Brief Title:
Phase II Trial of Low-Dose Whole Brain Radiotherapy With Concurrent Temozolomide and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma Multiforme
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
HP-00053043
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Maryland Baltimore
Lead Sponsor Class:
OTHER
Responsible Party:
Department of Radiation Oncology
Responsible Party Title:
Associate Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland Baltimore
Old Name:
None
Old Organization:
None